These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34112473)

  • 21. Chronic Urticaria in Older Adults: Treatment Considerations.
    Patruno C; Fabbrocini G; Cillo F; Torta G; Stingeni L; Napolitano M
    Drugs Aging; 2023 Mar; 40(3):165-177. PubMed ID: 36808569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic Urticaria and Angioedema: Masqueraders and Misdiagnoses.
    Bernstein JA; Ziaie N; Criado R; Criado PR; Rea S; Davis M
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2251-2263. PubMed ID: 37380071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acquired angioedema with C1-INH deficiency and accompanying chronic spontaneous urticaria in a patient with chronic lymphatic B cell leukemia].
    Klossowski N; Braun SA; von Gruben V; Losem C; Plewe D; Homey B; Meller S
    Hautarzt; 2015 Oct; 66(10):723-5. PubMed ID: 26335859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
    Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A
    Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi-center retrospective case series.
    Ari A; Levy Y; Segal N; Maoz-Segal R; Benor S; Broides A; Horev A; Epstein-Rigbi N; Agmon-Levin N; Marcus N
    Pediatr Dermatol; 2020 Nov; 37(6):1051-1054. PubMed ID: 32951239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Not Available].
    Svendsen SV; Lange NG; Christensen MJ; Mørtz CG; Bindslev-Jensen C
    Ugeskr Laeger; 2023 Dec; 185(49):. PubMed ID: 38078471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data.
    Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Maurer M; Weller K
    Allergy; 2018 Mar; 73(3):576-584. PubMed ID: 29058822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease.
    Martina E; Diotallevi F; Bianchelli T; Paolinelli M; Offidani A
    Curr Pharm Biotechnol; 2021; 22(1):32-45. PubMed ID: 32603278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angioedema is an unfavorable factor for the response to omalizumab in chronic spontaneous urticaria: A retrospective study.
    Serarslan G; Uzun M; Doğramacı AÇ; Çelik E
    Dermatol Ther; 2019 Jan; 32(1):e12752. PubMed ID: 30238582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Expanding Field of Biologics in the Management of Chronic Urticaria.
    Joshi S; Khan DA
    J Allergy Clin Immunol Pract; 2017; 5(6):1489-1499. PubMed ID: 28734860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and future therapies for the treatment of histamine-induced angioedema.
    James C; Bernstein JA
    Expert Opin Pharmacother; 2017 Feb; 18(3):253-262. PubMed ID: 28081650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omalizumab for the treatment of chronic urticaria.
    Zuberbier T; Maurer M
    Expert Rev Clin Immunol; 2015 Feb; 11(2):171-80. PubMed ID: 25566680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell-Mediated Angioedema.
    Maurer M; Magerl M
    Clin Rev Allergy Immunol; 2021 Aug; 61(1):40-49. PubMed ID: 33534062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Itch in Urticaria Management.
    Deza G; Giménez-Arnau AM
    Curr Probl Dermatol; 2016; 50():77-85. PubMed ID: 27578075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urticaria and Angioedema Across the Ages.
    Saini S; Shams M; Bernstein JA; Maurer M
    J Allergy Clin Immunol Pract; 2020 Jun; 8(6):1866-1874. PubMed ID: 32298850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema.
    Maurer M; Sofen H; Ortiz B; Kianifard F; Gabriel S; Bernstein JA
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):1056-1063. PubMed ID: 27911016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Treatment of Non-hereditary Angioedema.
    van den Elzen M; Go MFCL; Knulst AC; Blankestijn MA; van Os-Medendorp H; Otten HG
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):412-431. PubMed ID: 27672078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angioedema.
    Hahn J; Hoffmann TK; Bock B; Nordmann-Kleiner M; Trainotti S; Greve J
    Dtsch Arztebl Int; 2017 Jul; 114(29-30):489-496. PubMed ID: 28818177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical Management of New-Onset Urticaria and Angioedema Presenting in Primary Care, Urgent Care, and the Emergency Department.
    Macy E
    Perm J; 2021 Nov; 25():. PubMed ID: 35348101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic urticaria in childhood : Rational diagnostics and treatment].
    Ott H
    Hautarzt; 2017 Jul; 68(7):571-582. PubMed ID: 28474101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.